Most Foundayo side effects are gastrointestinal — nausea, constipation, diarrhoea, vomiting, indigestion and abdominal pain are the most commonly reported — and tend to be mild to moderate, improving over time, particularly after each dose increase. In the ATTAIN-1 trial, around 3–6% of people stopped treatment because of gastrointestinal side effects, compared with 0.7% on placebo. As a small-molecule tablet, Foundayo doesn't require the absorption-boosting ingredient used in the Wegovy pill, which may make it easier to tolerate for some people, though individual response always varies. Serious side effects are rare but require prompt medical attention.
Foundayo works by mimicking a hormone your body naturally releases after eating, activating GLP-1 receptors that regulate appetite and slow how quickly your stomach empties. That slower digestion is central to how the medicine helps you feel fuller for longer — but it's also the direct cause of most side effects, since a stomach that empties more slowly is more prone to nausea, bloating, and changes in bowel habits, particularly while your body is still adjusting. This is why side effects are most noticeable in the days following a dose increase, then typically ease as your body adapts before the next step.
Common Side Effects and How to Manage Them| Side effect | Practical management |
|---|---|
| Nausea | Eat smaller, more frequent meals; avoid high-fat or greasy food, particularly after a dose increase; eat slowly and stop before feeling overly full |
| Constipation | Increase fibre gradually through fruit, vegetables and wholegrains; drink water consistently through the day; gentle regular movement can help |
| Diarrhoea | Stay well hydrated; plain, low-fibre foods can help in the short term; contact your prescriber if it's severe or persistent |
| Vomiting | Sip fluids slowly to avoid dehydration; contact your prescriber if you can't keep fluids down or it continues beyond a day or two |
| Indigestion / heartburn | Avoid lying down straight after eating; smaller meals tend to help; avoid very spicy or acidic food during a flare-up |
| Abdominal pain | Mild discomfort is common, particularly early on; contact your prescriber if pain is severe, persistent, or accompanied by other symptoms |
For more detail on eating well while your appetite changes, including how to manage nausea through food choices, see our nutrition guide covering GLP-1 treatments.
Beyond the core gastrointestinal symptoms, Foundayo's trial programme also reported headache, abdominal distension (bloating), fatigue, belching, wind, hair loss and an increase in resting heart rate. Most of these are mild and don't require any specific action beyond monitoring.
Hair Loss
Hair thinning or shedding has been reported across the GLP-1 medicine class generally, not just with Foundayo, and is most often linked to the physiological stress of rapid weight loss itself — a pattern called telogen effluvium — rather than a direct toxic effect of the medicine. It's usually temporary and tends to resolve once weight stabilises. Adequate protein and micronutrient intake, covered in our nutrition guide, may help support hair health during treatment.
Increased Resting Heart Rate
A modest increase in resting heart rate has been observed with Foundayo, consistent with other medicines in the GLP-1 class. Your prescriber will monitor this as part of your ongoing care. Contact your prescriber if you notice a heart rate that feels persistently high, irregular, or is accompanied by chest pain, breathlessness or dizziness.
What Makes Foundayo's Side-Effect Profile a Little DifferentFoundayo is a small, non-peptide molecule — chemically closer to a conventional tablet than to a protein-based medicine — which means it can survive digestion and be absorbed without needing a specific absorption-enhancing ingredient. This matters because the Wegovy pill (oral semaglutide) is a peptide and requires an ingredient called SNAC to be absorbed properly, which is itself a recognised cause of stomach irritation for some people. Foundayo avoids this specific mechanism, which may make it more comfortable for some people to tolerate — though it's worth being balanced here: overall gastrointestinal side effects remain a feature of the GLP-1 class as a whole, and individual tolerability varies considerably from person to person regardless of formulation.
Worth knowing
Because Foundayo is a small molecule rather than a peptide, it doesn't need to be taken on an empty stomach or with the strict 30-minute waiting period required by the Wegovy pill. This is a genuine practical advantage, but it's separate from — and shouldn't be confused with — the question of which medicine causes fewer side effects overall, which current evidence doesn't clearly settle either way.
Important
Because Foundayo slows how quickly your stomach empties, it can reduce the absorption of oral hormonal contraceptives. According to Lilly's own patient guidance, this is a particular concern in the 30 days after starting Foundayo and in the 30 days following each dose increase. If you take a hormonal contraceptive pill, discuss this with your prescriber — you may be advised to use an additional barrier method (such as condoms) during these windows. Don't assume your existing contraception remains fully effective without checking.
Serious side effects are uncommon but require prompt attention. Contact NHS 111 urgently, or your prescriber, if you experience:
- Severe or persistent stomach problems
- Signs of dehydration that could affect your kidneys, such as reduced urination, dizziness or confusion
- Symptoms of acute pancreatitis, including severe abdominal pain that may spread to your back
- A severe allergic reaction
- A neck lump or swelling, hoarseness, trouble swallowing or shortness of breath
For emergencies, call 999 immediately. You can also report any suspected side effect to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk, which helps regulators continue monitoring Foundayo's safety profile as more people start treatment.
Managing Side Effects During TitrationBecause Foundayo's side effects tend to cluster around dose increases, it helps to know roughly what to expect at each stage of the titration schedule — see our full guide to Foundayo's dosage and titration schedule for the complete six-step timeline. If a particular dose is proving difficult, the standard approach is to stay at that dose for longer than the required minimum before increasing further, rather than pushing through significant discomfort. This isn't a failure of treatment — it's simply part of finding the right pace for your body.
Tracking Your Side EffectsKeeping a simple note of any side effects you notice — what they were, roughly how severe, and how they related to your last dose change — is genuinely useful, both for your own peace of mind and for your prescriber, who can use that pattern to judge whether your titration pace needs adjusting. This doesn't need to be complicated; a few lines in a notes app after each dose change is enough to spot patterns over time.
Who May Be More Likely to Experience Side EffectsWhile anyone can experience side effects on Foundayo, certain factors are worth being aware of and discussing openly with your prescriber during your consultation.
- A history of significant gastrointestinal issues, such as gastroparesis or severe reflux, may increase the likelihood or severity of GI side effects
- Rapid dose escalation, or moving up before you've properly adjusted to the previous dose, tends to produce more noticeable side effects — which is exactly why the titration schedule includes minimum waiting periods at each step
- Taking other medicines that also affect gut motility or absorption may interact with Foundayo's own effect on digestion
- Dehydration going into treatment can make gastrointestinal side effects, particularly constipation, more pronounced
None of these rule out treatment with Foundayo, but they're exactly the kind of detail worth being upfront about during your consultation, so your prescriber can plan your titration pace accordingly from the start rather than reacting after side effects appear.
Be the First to Know When Foundayo® Launches
Foundayo® was authorised by the MHRA on 10 August 2026 and is expected to reach UK pharmacies in the coming weeks. Register your interest and we will let you know as soon as it is available to order.
Register Your Interest → Happy Pharmacy is a GPhC-registered pharmacy (No. 9012585) — Superintendent Pharmacist: Palvinder Deol — Rated 4.8★ Excellent on Trustpilot- Foundayo® (orforglipron) Summary of Product Characteristics, MHRA Products website.
- Wharton S, et al. ATTAIN-1. N Engl J Med, September 2025.
- Orforglipron Maintains Weight Loss in Patients Switching from Semaglutide or Tirzepatide (ATTAIN-MAINTAIN). HCPLive, 2026.
- Wegovy® (oral semaglutide) tablets, UK Summary of Product Characteristics.
- MHRA. Yellow Card scheme — reporting suspected side effects of medicines.
- Eli Lilly and Company. Foundayo™ (orforglipron) Medication Guide and Digital Media Kit, lilly.com.
- Eli Lilly and Company. Foundayo™ (orforglipron) full Prescribing Information, pi.lilly.com.
- MHRA. Eli Lilly's new weight-loss pill orforglipron authorised by MHRA, 10 August 2026 — statement from Julian Beach, Executive Director of Healthcare Quality and Access.